Vanguard Global Advisers
GOCO

Vanguard Global Advisers’s GoHealth GOCO Stock Holding History

Vanguard Global Advisers’s Portfolio GOCO Stock Details GOCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,313
Closed -$1.98K – 3686
2026
Q1 		$1.98K Buy
+1,313
New +$2.51K ﹤0.01% 3615

Other funds holding GOCO

Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $19B AUM 51.73% 1-Year Est. Return
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.5B AUM 19.48% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 26.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Global Advisers's GOCO Position: Q2 2026 in Review

Vanguard Global Advisers sold out of GoHealth (GOCO) in Q2 2026, closing a stake of 1,313 shares — an estimated $1.98K sold.

Vanguard Global Advisers first reported a position in GOCO in Q1 2026 and held it in 1 quarter. The position peaked at $1.98K in Q1 2026. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

  • Vanguard Global Advisers reported no remaining GoHealth position as of Q2 2026 after selling out during the quarter.
  • Vanguard Global Advisers sold 1,313 GoHealth shares in Q2 2026, an estimated $1.98K.
  • Vanguard Global Advisers first reported a position in GoHealth in Q1 2026 and held it in 1 quarter.
  • Vanguard Global Advisers's GoHealth position peaked at $1.98K in Q1 2026.
  • 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.